Table 2

Pairwise epitope mapping of anti-Pg RIBS mAbs

Captured mAbSecond mAb, response units
20109495153116MOPC21
Group I        
    49 69.3 71.2 17.5 13.7 13.7 57.1 17 
    51 68.8 70.3 14.5 12.8 14.3 54.8 18.6 
    53 67.4 68.4 16.1 14.5 14.3 53.7 18.5 
Group II        
    20 9.7 15.4 43 41.4 40 72.1 7.7 
    109 26 25.1 62.1 60.7 61.1 100.4 17.2 
Group III        
    116 86.3 89.9 60.8 59.7 59.2 13.4 19.3 
Control        
    MOPC21 26.5 30 21.5 19.7 20.2 16.7 20.1 
Captured mAbSecond mAb, response units
20109495153116MOPC21
Group I        
    49 69.3 71.2 17.5 13.7 13.7 57.1 17 
    51 68.8 70.3 14.5 12.8 14.3 54.8 18.6 
    53 67.4 68.4 16.1 14.5 14.3 53.7 18.5 
Group II        
    20 9.7 15.4 43 41.4 40 72.1 7.7 
    109 26 25.1 62.1 60.7 61.1 100.4 17.2 
Group III        
    116 86.3 89.9 60.8 59.7 59.2 13.4 19.3 
Control        
    MOPC21 26.5 30 21.5 19.7 20.2 16.7 20.1 

Pairwise epitope mapping was performed and compared with the isotype control, MOPC21, as described in “Pairwise epitope mapping.” Results are representative of three profiling experiments.

or Create an Account

Close Modal
Close Modal